The Structural Heart Operating Unit develops therapies that treat patients with heart valve disease, including aortic, mitral, pulmonic, and tricuspid conditions. This role supports the Transcatheter Aortic Valve Implantation (TAVI) portfolio, including the Evolut platform, and the Transcatheter Pulmonic Valve (TPV) portfolio, including Melody and Harmony therapies.
This field-based position supports customers across the Northwest (Manchester, Blackpool, Liverpool and Leeds) territory, partnering with both clinical and non-clinical stakeholders involved in therapy adoption, patient pathways, and procedural delivery. Regular travel throughout the territory is required to support customer engagement, clinical cases, training activities, and account development.
This role combines territory management, therapy development, clinical support, and commercial execution to drive adoption of Structural Heart therapies. The successful candidate will work closely with healthcare providers to expand patient access, support procedural outcomes, and deliver commercial objectives across the TAVI and TPV portfolios.